Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is aggressive heparinization necessary for elective PTCA?

J H Frierson1, A P Dimas, C C Simpfendorfer

  • 1Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195.

Catheterization and Cardiovascular Diagnosis
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the experiences of people who have Postural Orthostatic Tachycardia Syndrome (POTS) and the health professionals who care for them: A grounded theory study.

International journal of nursing studies·2025
Same author

Pediatric neurogenic bowel dysfunction: ICCS review document.

Journal of pediatric urology·2023
Same author

Problematic substance use: an assessment of workplace implications in midwifery.

Occupational medicine (Oxford, England)·2021
Same author

Understanding the future research needs in Postural Orthostatic Tachycardia Syndrome (POTS): Evidence mapping the POTS adult literature.

Autonomic neuroscience : basic & clinical·2021
Same author

Vitamin retention during the canning of swordfish (Xiphias gladius) with different filling media.

Journal of food science·2021
Same author

Fatty acid profiles and lipid quality indices in canned European eels: Effects of processing steps, filling medium and storage.

Food research international (Ottawa, Ont.)·2020
Same journal

Early experience with the Bard XT stent.

Catheterization and cardiovascular diagnosis·1998
Same journal

Protection of side-branches in coronary lesions with a new stent design.

Catheterization and cardiovascular diagnosis·1998
Same journal

Imaging factors and image optimization.

Catheterization and cardiovascular diagnosis·1998
Same journal

Stenting of a renal artery bifurcation stenosis.

Catheterization and cardiovascular diagnosis·1998
Same journal

Intraarterial ethanol for the management of iatrogenic renal artery pseudoaneurysm.

Catheterization and cardiovascular diagnosis·1998
Same journal

Coronary stent for variant angina: atypical presentation.

Catheterization and cardiovascular diagnosis·1998
See all related articles

Routine monitoring of activated clotting time (ACT) is unnecessary during elective percutaneous transluminal coronary angioplasty (PTCA) with standard heparin doses. This study found no link between ACT levels and PTCA complications or thrombus formation.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • The optimal level of heparin anticoagulation for percutaneous transluminal coronary angioplasty (PTCA) remains undetermined.
  • Assessing the relationship between anticoagulation levels and PTCA complications is crucial for patient safety.

Purpose of the Study:

  • To investigate whether percutaneous transluminal coronary angioplasty (PTCA) complications correlate with activated clotting time (ACT) levels.
  • To evaluate the necessity of routine ACT monitoring during elective PTCA procedures.

Main Methods:

  • Prospective measurement of serial activated clotting time (ACT) values in 189 patients undergoing 201 elective PTCA procedures.
  • Standard heparin dosing protocols were administered, with mean pre-inflation dose of 10,100 units and mean procedural dose of 13,200 units.

Related Experiment Videos

  • Analysis of ACT parameters in relation to acute complications and intracoronary thrombus development.

    • Main Results:

    • The mean pre-inflation ACT was 295 seconds, with over 50% of patients having ACT < 300 seconds.
    • No significant relationship was found between any ACT parameter and the occurrence of acute complications.
    • No new intracoronary thrombus was observed in any of the procedures.

    Conclusions:

    • Routine monitoring of activated clotting time (ACT) is not necessary for elective percutaneous transluminal coronary angioplasty (PTCA) when standard heparin doses are employed.
    • Current heparin dosing strategies appear sufficient to prevent complications and thrombus formation during elective PTCA, obviating the need for frequent ACT checks.